Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.
| Image |  |
|---|---|
| Description | scientific article published on 11 April 2018 |
| Author/s | |
| Publication date | April 11, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |